Organization Overview
Historical Acquisition Tree
Alternative names
Key: Sanofi-Aventis (46) Acquired (39)
acetaminophen (tylenol) (1982)
acetylsalicylic acid (aspirin) (1975)
aflibercept (zaltrap) (2012 NDA)
alirocumab (praluent) (2015 NDA)
aluminum hydroxide (Gaviscon) (1983)
ambenonium chloride (mytelase) (1956 NDA)
amrinone (inocor) (1984 NDA)
betaxolol (kerlone) (1989)
bitolterol (tornalate) (1984 NDA)
cabazitaxel (jevtana kit) (2010 NDA)
calcitonin salmon (Calcimar) (1978)
cefotaxime (claforan) (1987)
chlormezanone (trancopal) (1960 NDA)
chloroquine (1949)
chlorthalidone (Hygroton) (1960)
clomifene (clomid) (1967)
clopidogrel (plavix) (1997)
corticotropin (acthar) (1950 NDA)
cyanocobalamin (berocca) (1982)
danazol (danocrine) (1976 NDA)
daunorubicin (cerubidine) (1980)
desipramine (pertofrane) (1968)
diethylpropion hydrochloride (tenuate) (1975)
docetaxel (taxotere) (1996)
doxylamine (1948)
dronedarone (multaq) (2009 NDA)
eflornithine (ornidyl) (1990 NDA)
enoxacin (penetrex) (1991 NDA)
enoxaparin (lovenox) (1993 NDA)
fexofenadine (allegra) (1996 NDA)
fludarabine (fludara) (2008)
furosemide (lasix) (1968)
glimepiride (amaryl) (1995 NDA)
glutethimide (doriden) (1957 NDA)
glyburide (micronase) (1984)
hexachlorophene (1949)
hydrochlorothiazide (esidrix) (1997)
hydroxystilbamidine isetionate (1953)
imipramine (tofranil) (1959)
indapamide (lozol) (1983 NDA)
insulin glargine (toujeo) (2015)
insulin glulisine (Apidra) (2004)
insulin lispro (humalog) (2017)
irbesartan (avapro) (1997)
iron dextran (1957)
Isatuximab (Sarclisa) (2020)
isoniazid (nydrazid) (1975)
isoprenaline (1948)
lactulose (cephulac) (1976 NDA)
leflunomide (arava) (1998 NDA)
levocetirizine (xyzal) (2007)
lixisenatide (adlyxin) (2016 NDA)
magnesium trisilicate (1983)
mepenzolate bromide (cantil) (1956 NDA)
milrinone (primacor) (1987 NDA)
nalidixic acid (neggram) (1964 NDA)
naloxone (narcan) (1982)
nedocromil (tilade) (1997)
niacin (1973)
nicotine (nicorette) (1991)
nitroglycerin (transderm-nitro) (1982)
oxaliplatin (eloxatin) (2002)
pentacel (2008 NDA)
pentazocine (talwin) (1969)
phenylbutazone (butazolidin) (1981)
primaquine (1952 NDA)
probucol (lorelco) (1977 NDA)
pseudoephedrine (Benylin) (1975)
pyrazinamide (Aldinamide) (1994)
pyridoxine (1956)
reserpine (serpasil) (1964)
rifampin (1971)
rifapentine (priftin) (1998)
sodium ferric gluconate complex (1999)
talbutal (lotusate) (1954)
tamsulosin (flomax) (1997 NDA)
telithromycin (ketek) (2004)
terbutaline (bricanyl) (1974 NDA)
teriflunomide (aubagio) (2012 NDA)
theophylline (synophylate) (1979)
thyrotropin (thyropar) (1953)
tiludronate (Skelid) (1997)
triamcinolone (kenalog) (1991)
trichlormethiazide (naqua) (1988)
zolpidem (ambien) (1992)
Key: Sanofi-Aventis (5) Acquired (217)
abiraterone (zytiga) (7 trials)
acetaminophen (tylenol) (10 trials)
acetylsalicylic acid (aspirin) (12 trials)
aciclovir (zovirax) (5 trials)
adefovir dipivoxil (hepsera) (1 trial)
agalsidase alfa (Replagal) (2 trials)
agalsidase beta (fabrazyme) (15 trials)
alemtuzumab (campath) (34 trials)
alfuzosin (uroxatral) (26 trials)
alglucosidase alfa (myozyme) (31 trials)
alirocumab (praluent) (51 trials)
amodiaquine (camoquin) (10 trials)
amphotericin b (fungizone) (1 trial)
antihemophilic factor viii (Recombinant) (Adynovate) (7 trials)
Anti-thymocyte Globulin (Rabbit) (Thymoglobulin) (42 trials)
atenolol (tenormin) (2 trials)
atorvastatin (lipitor) (22 trials)
autologous culture chondrocytes (Carticel) (4 trials)
azathioprine (imuran) (2 trials)
azithromycin (zithromax) (7 trials)
basiliximab (simulect) (3 trials)
benzoyl peroxide (clearasil) (2 trials)
bisacodyl (Halflytely) (2 trials)
bivalent oral polio vaccine (bopv), type 1 and type 3 (7 trials)
bortezomib (velcade) (13 trials)
budesonide (rhinocort) (3 trials)
cabazitaxel (jevtana kit) (58 trials)
carboplatin (paraplatin) (54 trials)
cetirizine (zyrtec) (3 trials)
ciprofloxacin (cipro) (2 trials)
cisplatin (platinol) (70 trials)
clarithromycin (biaxin) (2 trials)
clindamycin (cleocin) (2 trials)
clopidogrel (plavix) (39 trials)
diphenhydramine (benadryl) (12 trials)
diphtheria-tetanus-acellular pertussis-inactivated poliovirus-haemophilus influenzae b conjugate-hepatitis b vaccine (10 trials)
docetaxel (taxotere) (246 trials)
doxercalciferol (hectorol) (8 trials)
dronedarone (multaq) (17 trials)
dtap-ipv mkc vaccine (4 trials)
dupilumab (dupixent) (78 trials)
enoxaparin (lovenox) (41 trials)
enzalutamide (xtandi) (4 trials)
esomeprazole (nexium) (1 trial)
everolimus (zortress) (2 trials)
felodipine (plendil) (2 trials)
fenofibrate (fenoglide) (8 trials)
fexofenadine (allegra) (17 trials)
filgrastim (neupogen) (12 trials)
fludarabine (fludara) (17 trials)
fluorouracil (efudex) (91 trials)
glatiramer acetate (copaxone) (5 trials)
glimepiride (amaryl) (22 trials)
glipizide (glucotrol) (1 trial)
glucagon-like peptide-1 (2 trials)
glyburide (micronase) (3 trials)
granisetron (kytril) (1 trial)
haloperidol (haldol) (1 trial)
heparin (liquaemin) (8 trials)
hepatitis a vaccine, inactivated (vaqta) (7 trials)
hydrochlorothiazide (esidrix) (12 trials)
hydroxychloroquine (plaquenil) (9 trials)
icosapent ethyl (vascepa) (3 trials)
imiglucerase (cerezyme) (6 trials)
inactivated hav vaccine, lu8 strain (1 trial)
inactivated hep a vaccine (1 trial)
inactivated influenza vaccine (124 trials)
insulin aspart (novolog) (7 trials)
insulin degludec (tresiba) (5 trials)
insulin detemir (Levemir) (5 trials)
insulin glargine (toujeo) (178 trials)
insulin glulisine (Apidra) (63 trials)
insulin human (humulin) (60 trials)
insulin lispro (humalog) (23 trials)
ketoprofen (orudis) (5 trials)
killed oral cholera vaccine (7 trials)
laronidase (aldurazyme) (9 trials)
leflunomide (arava) (9 trials)
leuprolide (lupron) (7 trials)
levofloxacin (levaquin) (4 trials)
levothyroxine (Synthroid) (4 trials)
liraglutide (victoza) (6 trials)
live attenuated chimeric japanese encephalitis vaccine (8 trials)
live attenuated influenza virus vaccine (flumist) (2 trials)
live attenuated varicella vaccine (11 trials)
live oral poliovirus type 1, 2 and 3 (1 trial)
lixisenatide (adlyxin) (49 trials)
loratadine (claritin) (3 trials)
lumefantrine (Coartem) (5 trials)
measles, mumps and rubella vaccine (4 trials)
menacwy conjugate vaccine (53 trials)
metformin (glucophage) (11 trials)
methylprednisolone (medrol) (8 trials)
metoclopramide (reglan) (1 trial)
metoprolol (lopressor) (5 trials)
metronidazole (flagyl) (1 trial)
montelukast (singulair) (5 trials)
mycophenolate (myfortic) (15 trials)
naltrexone (revia) (15 trials)
nateglinide (starlix) (1 trial)
olanzapine (zyprexa) (2 trials)
ondansetron (zofran) (2 trials)
oxaliplatin (eloxatin) (148 trials)
paliperidone (invega) (1 trial)
paricalcitol (zemplar) (2 trials)
pioglitazone (actos) (7 trials)
plerixafor (mozobil) (57 trials)
pneumococcal 13-valent conjugate vaccine (prevnar 13) (25 trials)
poliovirus vaccine inactivated (8 trials)
polyene phosphatidylcholine (1 trial)
potassium iodide (thyro-block) (1 trial)
prasugrel (effient) (2 trials)
prednisone (meticorten) (51 trials)
procaine benzylpenicillin (novocaine) (6 trials)
pyrimethamine (daraprim) (1 trial)
rabies vaccine (purified chick embryo cell vaccine) (RabAvert) (8 trials)
ranitidine (zantac) (12 trials)
rasburicase (elitek) (14 trials)
recombinant influenza vaccine (2 trials)
repaglinide (prandin) (2 trials)
ribavirin (virazole) (2 trials)
risedronate (actonel) (32 trials)
risperidone (risperdal) (2 trials)
rituximab (rituxan) (17 trials)
rosuvastatin (crestor) (15 trials)
rotavirus vaccine, live, oral, pentavalent (rotateq) (11 trials)
sargramostim (leukine) (56 trials)
sarilumab (kevzara) (30 trials)
sevelamer (renagel) (25 trials)
sirolimus (rapamune) (9 trials)
sitagliptin (januvia) (67 trials)
sulfasalazine (azulfidine) (4 trials)
tacrolimus (prograf) (14 trials)
telithromycin (ketek) (21 trials)
tenecteplase (tnkase) (2 trials)
teriflunomide (aubagio) (24 trials)
testosterone (delatestryl) (1 trial)
tetanus-diphtheria toxoid (3 trials)
thyrotropin alfa (thyrogen) (3 trials)
tirofiban (aggrastat) (1 trial)
tofogliflozin hydrate (2 trials)
triamcinolone (kenalog) (8 trials)
valproic acid (depakene) (7 trials)
vancomycin (Vancocin) (1 trial)
Key: Sanofi-Aventis (26) Acquired (248)
10-valent Pneumococcal Conjugate Vaccine (Pneumosil) (1 trial)
23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (2 trials)
adalimumab (humira) (2 trials)
aflibercept (zaltrap) (40 trials)
albiglutide (tanzeum) (1 trial)
albumin (Human) (Plasbumin) (2 trials)
aldesleukin (proleukin) (7 trials)
allogeneic lymphocytes (1 trial)
allogeneic prostate vaccine (1 trial)
allopurinol (zyloprim) (3 trials)
amiodarone (cordarone) (2 trials)
amlodipine (norvasc) (4 trials)
antihemophilic factor viii human (Hemofil M) (3 trials)
antihemophilic factor viii (Recombinant), Fc-fusion protein (Eloctate) (8 trials)
anti-inhibitor coagulant complex (activated prothrombin complex concentrate) (Autoplex-T) (1 trial)
antirabies serum (equine) (2 trials)
antithrombin iii (human) (thrombate iii) (1 trial)
avobenzone (shade uvaguard) (2 trials)
bevacizumab (avastin) (43 trials)
bicalutamide (casodex) (4 trials)
bifidobacterium longum (1 trial)
bivalent subtype c gp120 (4 trials)
calcitriol (rocaltrol) (4 trials)
capecitabine (xeloda) (72 trials)
caplacizumab (cablivi) (8 trials)
carfilzomib (kyprolis) (5 trials)
c. difficile toxoid vaccine (2 trials)
cemiplimab (libtayo) (28 trials)
cetuximab (erbitux) (18 trials)
cetylpyridinium chloride (2 trials)
cholestyramine (questran) (6 trials)
ciclesonide (alvesco) (4 trials)
clobetasol (dermovate) (1 trial)
clofarabine (clolar) (62 trials)
coagulation factor ix (Recombinant) (Rixubis) (3 trials)
coagulation factor ix (Recombinant), Fc-fusion protein (Alprolix) (7 trials)
coagulation factor viia (recombinant) (NovoSevenRT) (1 trial)
cyclophosphamide (cytoxan) (44 trials)
cyclosporine (sandimmune) (8 trials)
cytarabine (cytosar-u) (18 trials)
dalfopristin (Synercid) (1 trial)
daunorubicin (cerubidine) (3 trials)
doxorubicin (Doxil) (27 trials)
dulaglutide (trulicity) (2 trials)
eliglustat (cerdelga) (13 trials)
empagliflozin (jardiance) (3 trials)
epirubicin (ellence) (15 trials)
eptifibatide (integrilin) (2 trials)
erlotinib (tarceva) (18 trials)
escitalopram (lexapro) (6 trials)
estramustine (emcyt) (5 trials)
ethambutol (myambutol) (2 trials)
etoposide (vepesid) (10 trials)
fedratinib (Inrebic) (11 trials)
finasteride (Proscar) (1 trial)
fluocinolone acetonide (synalar) (1 trial)
fluticasone (cutivate) (7 trials)
fluvastatin (lescol) (5 trials)
fondaparinux sodium (arixtra) (3 trials)
gemcitabine (gemzar) (61 trials)
goserelin (zoladex) (2 trials)
gvax prostate cancer vaccine (6 trials)
haemophilus b conjugate vaccine diphteria crm197 protein conjugate (Menveo) (2 trials)
haemophilus influenzae type b conjugate vaccine (PedvaxHIB) (3 trials)
haemophilus influenzae type b-neisseria meningitidis serogroups c and y-tetanus-toxoid conjugate vaccine (1 trial)
hemopoietic stem cell (1 trial)
hepatitis b immune globulin (human) (BayHep B) (1 trial)
hepatitis b vaccine (recombinant) (recombivax) (12 trials)
hexavalent pneumococcal polysaccharide vaccine (1 trial)
hpv 16/18 vaccine (Cervarix) (2 trials)
human coagulation factor ix (Mononine) (2 trials)
human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)
human rotavirus, live attenuated (Rotarix) (3 trials)
human rotavirus rix4414 strain vaccine (1 trial)
hybrid 5 component dtap, vero ipv, hep b and prp-ompc (3 trials)
hydrocortisone (solu-cortef) (1 trial)
hylan g-f 20 (gz/sar402662) (1 trial)
inactivated japanese encephalitis vaccine (Ixiaro) (7 trials)
inactivated poliovirus type 2 vaccine (1 trial)
inactivated rabies vaccine (Imovax) (7 trials)
inactivated varicella vaccine (2 trials)
infanrix hexa vaccine (1 trial)
influenza vaccine, recombinant hemagglutinin (7 trials)
interferon beta-1b (betaseron) (4 trials)
ipilimumab (yervoy) (5 trials)
irinotecan (Camptosar) (43 trials)
Isatuximab (Sarclisa) (41 trials)
isoniazid (nydrazid) (3 trials)
lactobacillus paracasei (1 trial)
lenalidomide (revlimid) (12 trials)
levobupivacaine (chirocaine) (1 trial)
levocarnitine (carnitor) (1 trial)
lidocaine (xylocaine) (1 trial)
live, attenuated, dengue serotype 1, 2, 3, 4 virus (11 trials)
live tetravalent chimeric dengue vaccine (15 trials)
lovastatin (mevacor) (2 trials)
measles, mumps, rubella, varicella vaccine (7 trials)
meningococcal a&c vaccine (2 trials)
meningococcal polysaccharide vaccine, group c (1 trial)
migalastat (galafold) (1 trial)
mipomersen (kynamro) (18 trials)
mitoxantrone (novantrone) (5 trials)
modafinil (provigil) (1 trial)
mometasone (elocon) (5 trials)
moxifloxacin (avelox) (2 trials)
olipudase alfa (Xenpozyme) (4 trials)
omega-3 fatty acids (omacor) (2 trials)
omeprazole (prilosec) (9 trials)
paclitaxel (taxol) (20 trials)
palbociclib (ibrance) (2 trials)
peginterferon beta-1a (Plegridy) (5 trials)
pembrolizumab (keytruda) (8 trials)
pemetrexed (alimta) (11 trials)
phenprocoumon (liquamar) (1 trial)
phenylephrine (Prefrin) (1 trial)
piperacillin (pipracil) (1 trial)
pitavastatin (livalo) (3 trials)
pneumococcal 7-valent conjugate vaccine (prevnar) (3 trials)
pomalidomide (pomalyst) (8 trials)
pravastatin (pravachol) (5 trials)
prednisolone (hydeltra) (6 trials)
prilocaine (citanest) (1 trial)
pyrazinamide (Aldinamide) (2 trials)
quadrivalent groups a, c, y, and w-135 meningococcal vaccine (Menomune-A/C/Y/W-135) (12 trials)
rabies immune globulin (human) (Kedrab) (2 trials)
riferminogene pecaplasmid (6 trials)
sars-cov-2 adjuvanted recombinant protein vaccine (bivalent) (1 trial)
sars-cov-2 adjuvanted recombinant protein vaccine (monovalent) (1 trial)
serogroup b meningococcal vaccine (2 trials)
simvastatin (zocor) (12 trials)
sodium polystyrene sulfonate (kayexalate) (4 trials)
somatropin (protropin) (3 trials)
sorafenib (nexavar) (5 trials)
split virion influenza vaccine (2 trials)
spores of bacillus clausii (1 trial)
sutimlimab (Enjaymo) (4 trials)
tamoxifen (nolvadex) (1 trial)
t cell depleted hematopoietic stem cells (1 trial)
telmisartan (micardis) (1 trial)
ticlopidine (ticlid) (2 trials)
tocilizumab (actemra) (4 trials)
tolevamer potassium sodium (1 trial)
topotecan (hycamtin) (6 trials)
trastuzumab (herceptin) (24 trials)
typhoid vi polysaccharide vaccine (Typhim Vi) (1 trial)
vinorelbine (navelbine) (14 trials)
warfarin (coumadin) (9 trials)
Key: Sanofi-Aventis (13) Acquired (222)
4'-hydroxydesazadesferrithiocin (1 trial)
adenosine (Adenocard) (1 trial)
albumin iodinated i-131 serum (megatope) (1 trial)
albuterol (proventil) (2 trials)
allogeneic dendritic cells (1 trial)
allogeneic stem cells (4 trials)
aluminum hydroxide (Gaviscon) (1 trial)
alvac melanoma multi-antigen therapeutic vaccine (1 trial)
apalutamide (erleada) (1 trial)
apomorphine (apokyn) (3 trials)
arsenic trioxide (trisenox) (1 trial)
atezolizumab (tecentriq) (2 trials)
autologous mononuclear stem cell (1 trial)
autologous rcc tumor derived cells (1 trial)
autologous skeletal myoblast (1 trial)
autologous tumor cells (1 trial)
bacille calmette-guerin (2 trials)
bendamustine (treanda) (2 trials)
betamethasone (celestone) (2 trials)
bivalent cyd-1,3 dengue (1 trial)
bivalent cyd-2,4 dengue (1 trial)
brivudine phosphoramidate (1 trial)
cobimetinib (cotellic) (1 trial)
coltuximab ravtansine (5 trials)
cromoglicic acid (Intal) (1 trial)
decitabine (dacogen) (3 trials)
deferoxamine (desferal) (1 trial)
dendritic cell-gp100-mart-1 antigen vaccine (1 trial)
dendritic cell tumor fusion vaccine (1 trial)
diethylstilbestrol (Fosfestrol) (1 trial)
donepezil (aricept) (2 trials)
donor lymphocyte preparation depleted of functional host alloreactive t-cells (1 trial)
donor t-lymphocytes depleted ex vivo of host alloreactive t-cells (1 trial)
electrofusion dc vaccine (1 trial)
erythromycin (ilosone) (1 trial)
florbetapir (Amyvid) (1 trial)
fludeoxyglucose f-18 (1 trial)
formoterol (foradil) (2 trials)
fulvestrant (faslodex) (2 trials)
gabapentin (neurontin) (1 trial)
gp-100 peptide vaccine (1 trial)
gvax pancreatic cancer vaccine (3 trials)
heat killed e. coli (2 trials)
human papillomavirus quadrivalent (types 6, 11, 16 and 18) vaccine, recombinant (Gardasil) (1 trial)
idarubicin (idamycin) (4 trials)
immune globulin (human) (2 trials)
inactivated SARS-Cov-2 vaccine (1 trial)
interferon alpha-2a (roferon-a) (1 trial)
interferon alpha-2b (Intron-A) (1 trial)
killed escherichia coli k12 (1 trial)
levalbuterol (xopenex) (2 trials)
Live-Attenuated Respiratory Syncytial Virus Vaccine (1 trial)
melphalan (alkeran) (2 trials)
mercaptopurine (purinethol) (1 trial)
methylphenidate (ritalin) (1 trial)
multicomponent meningococcal b vaccine (1 trial)
nolpitantium besylate (1 trial)
octreotide (sandostatin) (1 trial)
pegaspargase (oncaspar) (2 trials)
peripheral blood hematopoietic cell (3 trials)
polymyxin b sulfate (poly-rx) (1 trial)
polysaccharide diphtheria conjugate vaccine (1 trial)
polysaccharide diphtheria toxoid conjugate vaccine (1 trial)
ramucirumab (cyramza) (2 trials)
recombinant adenoviral human p53 gene (1 trial)
recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)
recombinant sars-cov-2 vaccine (1 trial)
regadenoson (lexiscan) (1 trial)
reproterol hydrochloride (1 trial)
rifapentine (priftin) (4 trials)
rotavirus vaccine, live, oral, tetravalent (RotaShield) (3 trials)
rubidium chloride rb-82 (1 trial)
sildenafil (viagra) (2 trials)
smallpox vaccine, heat-stable freeze-dried powder, first generation (3 trials)
smallpox vaccine, lister strain (1 trial)
smallpox vaccine, tissue culture adapted jennerian (ACAM2000) (3 trials)
sp0202-vii pneumococcal conjugate vaccine (1 trial)
temozolomide (temodar) (5 trials)
thyrotropin (thyropar) (3 trials)
timothy grass pollen allergen extract (Grastek) (1 trial)
tolterodine (detrol) (2 trials)
trilostane (modrastane) (1 trial)
vasopressin v2 receptor antagonist (1 trial)
vincristine (oncovin) (4 trials)
Key: Sanofi-Aventis (11) Acquired (88)
acetylcholine chloride (miochol) (1 trial)
acid sphingomyelinase (2 trials)
alendronic acid (fosamax) (1 trial)
alvac(2)-ny-eso-1 (m)/tricom vaccine (1 trial)
becaplermin (regranex) (1 trial)
colestipol (colestid) (1 trial)
crushed garlic clove (1 trial)
emtricitabine (emtriva) (1 trial)
ga-do3a-vs-cys40-tuna-2 (1 trial)
gemtuzumab ozogamicin (mylotarg) (1 trial)
itraconazole (sporanox) (1 trial)
latanoprost (xalatan) (1 trial)
naphazoline (visine) (1 trial)
palonosetron (aloxi) (1 trial)
pantoprazole (protonix) (2 trials)
pentoxifylline (trental) (1 trial)
pneumococcal protein vaccine (1 trial)
rabeprazole (pariet) (1 trial)
Key: Sanofi-Aventis (0) Acquired (30)
Acquired Immunodeficiency Syndrome (Phase 3)
Anemia, Sickle Cell (Phase 2)
Asthma (Phase 4)
Bacterial Infections (Phase 3)
Bipolar Disorder (Phase 4)
Carcinoma, Ductal (Phase 2)
Carcinoma, Ovarian Epithelial (Phase 1)
Chickenpox (Phase 4)
Cholera (Phase 4)
Clostridium Infections (Phase 2)
Communicable Diseases (Phase 3)
Cytomegalovirus Infections (Phase 2)
Dengue (Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diphtheria (Phase 4)
Dyslipidemias (Phase 4)
Dysmenorrhea (Phase 4)
Encephalitis (Phase 4)
Encephalitis, Japanese (Phase 4)
Fallopian Tube Neoplasms (Phase 1)
Fever (Phase 3)
Gastroenteritis (Phase 4)
Haemophilus Infections (Phase 4)
Hemophilia A (Phase 3)
Hemorrhagic Fevers, Viral (Phase 3)
Hepatitis (Phase 4)
Hepatitis A (Phase 4)
Hepatitis B (Phase 3)
Herpes Genitalis (Phase 2)
Herpes Simplex (Phase 1)
Herpes Zoster (Phase 4)
HIV Infections (Phase 3)
Hyperuricemia (Phase 4)
Immunologic Deficiency Syndromes (Phase 3)
Infarction (Phase 4)
Infections (Phase 3)
Influenza, Human (Phase 4)
Influenza in Birds (Phase 1)
Lung Diseases (Phase 4)
Lung Diseases, Obstructive (Phase 4)
Measles (Phase 4)
Meningitis (Phase 4)
Meningitis, Meningococcal (Phase 4)
Meningococcal Infections (Phase 4)
Multiple Sclerosis (Phase 2)
Myocardial Infarction (Phase 4)
Orthomyxoviridae Infections (Phase 4)
Osteoporosis (Phase 4)
Osteoporosis, Postmenopausal (Phase 4)
Otitis (Phase 3)
Otitis Media (Phase 3)
Pancreatic Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 1)
Pneumococcal Infections (Phase 3)
Pneumonia (Phase 1)
Pneumonia, Pneumococcal (Phase 1)
Poliomyelitis (Phase 4)
Pulmonary Disease, Chronic Obstructive (Phase 4)
Purpura (Phase 1)
Purpura, Thrombocytopenic (Phase 1)
Purpura, Thrombocytopenic, Idiopathic (Phase 2)
Rabies (Phase 3)
Recurrence (Phase 4)
Respiratory Syncytial Virus Infections (Phase 2)
Rotavirus Infections (Phase 3)
Rubella (Phase 4)
Salmonella Infections (Phase 3)
Schizophrenia (Phase 4)
Sclerosis (Phase 2)
Severe Dengue (Phase 3)
Tetanus (Phase 4)
Tetany (Phase 4)
Thrombocytopenia (Phase 2)
Tuberculosis (Phase 2)
Tumor Lysis Syndrome (Phase 4)
Typhoid Fever (Phase 3)
Vaginal Diseases (Phase 4)
Vaginosis, Bacterial (Phase 4)
Viremia (Phase 1)
Virus Diseases (Phase 3)
Whooping Cough (Phase 4)
Yellow Fever (Phase 2)